RIVASVT-100
Treatment of portal, mesenteric, and splenic vein thrombosis with rivaroxaban. A pilot, prospective cohort study
Registration:
(Clinicaltrials.gov) NCT02627053
Sponsors:
Università degli Studi dell'Insubria
Varese, Italy
Status:
- Recruited started 2015
Design
Prospective pilot cohort study investigating treatment of portal, mesenteric, and splenic vein thrombosis with rivaroxaban
Participating Sites
Lead Network:
TRIP
Countries:
Canada, France, Germany, Italy,Lead Investigators
Walter Ageno, MD
walter.ageno@uninsubria.itSubscribe